Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on ATI-1801 and preparing ATI-1701 for an Inv ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations ...
Tim Heis left the high-end luxe world of Neiman Marcus for a scattered collection of North Texas Goodwill thrift stores. He ...
Purple peel exploit stands at the core of a groundbreaking revelation announced by research scientist Andrew Lambert, ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Zoetis Inc. $157.52-7.41-4.49% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback